Financials

  • Market Capitalization 15.76 M
  • Employee 29
  • Founded 1986
  • CEO Carl Spana
  • Website www.palatin.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BN9PY4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
4.79
Relación precio/flujo de caja
1.91

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4653
SNTI
Senti Biosciences, Inc. - Common Stock
0.58 USD-40.21%-44.23%-39.58%-39.08%18.06 M USD
4671
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.34 USD0.00%-5.56%-12.82%-74.24%16.52 M USD
4679
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.48 USD0.00%-5.88%-11.11%-27.27%16.04 M USD
4688
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.71 USD-3.13%+6.61%+17.78%+16.67%16.07 M USD

Noticias